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ABSTRACT 
Objective: To study the effect of betulin derivatives combination with 5-fluorouracil or hydrazine sulfate on the ROS generation, the SOD and LDH 
activity using rat blood, as well as the effect of combination drugs on Ehrlich carcinoma in experiments on mice. 
Methods: We used a chemiluminescence technique to study the ROS generation, and spectrophotometry to determine the MDA level and the SOD 
and LDH activity. The model of transplanted Ehrlich ascites carcinoma was investigated on mice using a cytological analysis of ascitic fluid cells 
according to Pappenheim`s method. 
Results: In vitro experiments on rat blood at the doses of 2, 5 and 10 μg per ml revealed the dose-dependent effect of combination drugs on the 
antioxidant properties. In plasma, the ROS generation and the MDA level increased by 10-300% in comparison with control at the doses of 5 and 10 
μg per ml only. Still, the SOD and LDH activity in general increased by 10-130% in comparison with control under the action of the studied 
combination drugs. The study on mice showed the effectiveness of a combination of triterpenoids and cytostatics in Ehrlich ascites carcinoma 
therapy. The state and behavior of the animals improved, the volume of ascites fluid decreased by 40-50% after treatment for 10 d. 
Conclusion: The combination of betulin derivatives with cytostatics can be used as antitumor drugs in Ehrlich ascites carcinoma therapy that is due 
to metabolic plasticity, increased ROS generation in enhanced antioxidant enzyme protection. 
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INTRODUCTION 
The high toxicity and many undesirable side effects of anticancer 
drugs are one of the problems in tumor treatment because it leads to 
patients` life quality deterioration. In this regard, some novel 
chemotherapy that will enable to a reduction of anticancer drug 
doses and side effects is needed. 
The most promising approach in therapy is the use of natural substances 
with cytotoxic activity concerning tumor cells but not affecting healthy 
ones. Such substances include lupane triterpenoids–betulin, betulinic 
and betulonic acids and their derivatives [1-7]. Recent studies have 
shown that the combination of triterpenoids such as oleanolic, ursolic 
and betulinic acids with 5-fluorouracil might be a useful tool with 
reduced doses of an anticancer drug–5-fluorouracil and without any side 
effects. Triterpenoids are able to potentiate the 5-fluorouracil effect by 
affecting different stages of esophageal carcinoma and other tumors [8, 
9]. Previously, we showed the animals state improvement indicated by 
survival, body weight, wool, behavior, reduced cardiotoxicity when 
Ehrlich carcinoma was treated by the combination of 5-fluorouracil or 
hydrazine sulfate with betulin-3,28-diphosphate in in vivo experiment 
[10]. The effect may be due to the decreased dose of high toxic 
cytostatics and increased metabolic processes in an animal body, 
including antioxidant enzyme protection and energy metabolism 
activation. Hydrazine sulfate is an insufficiently explored antitumor 
agent; it inhibits monoamine oxidase and blocks gluconeogenesis by 
phosphoenol-pyruvate carboxylase [11]. 5-fluorouracil inhibits 
thymidylate synthase, disrupts the synthesis of the nuclear acids 
resulting in the apoptosis of tumor cells [12]. 
The generation of reactive oxygen species (ROS) in tumor cells is one 
of the reasons for apoptosis onset, which does not depend on an 
apoptotic mechanism. Therefore, when developing new drugs, it is 
necessary to take into account the balance of antioxidant and 
prooxidant properties, the ROS generation, as well as the SOD, 
catalase and glutathione peroxidase activity. 
Another essential reason for apoptosis is the change of energy 
metabolism–mainly glycolysis and oxidative phosphorylation in a 
tumor cell, that can be assessed by the lactate dehydrogenase 
activity. The influence of drugs on these processes in cancer cells 
and healthy cells is an object of intensive research. There been 
discussed the predominance of active glycolysis (Warburg effect) or 
oxidative phosphorylation (Warburg reversal effect) in the growth 
of tumor cells. It has been demonstrated that metabolic plasticity — 
the transformation of glycolysis to oxidative metabolism in in vitro 
experiments can be observed in tumors. Due to the decrease of 
mitochondrial oxidative phosphorylation, less reactive oxygen 
species are generated, they being cytotoxic to cancer cells [13]. 
The present study considers the antioxidant and metabolic 
properties in in vitro experiments, and antitumor activity of the 
combination drugs of betulin-3,28-diacetate and betulonic acid with 
cytostatics (5-fluorouracil and hydrazine sulfate) on mice. 
The influence of betulin derivatives on the competition of these 
processes is important. At the same time, there are no data on the 
inhibition or activation of glycolysis and phosphorylation under 
these compound's action. In this work we studied ROS generation in 
Fenton reaction using chemiluminescence, evaluation of the MDA 
level and the SOD activity, the assessment of the LDH catalytic 
activity in direct and reverse reactions in plasma and erythrocytes. 
Antitumor activity was studied on the transplanted Ehrlich ascites 
carcinoma model in mice using the data on cytological analysis, the 
volume of ascitic fluid, and the state of animals. 
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Fig. 1: Formulas of combination drugs components 
 
MATERIALS AND METHODS 
Materials 
Betulin was isolated from Betula Pendula bark. The Betula Pendula 
Roth bark was obtained from Bor forestry of the Nizhny Novgorod 
region, the samples of the bark were compared with ones obtained 
from the Biocollections of the VILAR Botanical Garden (voucher 
specimen No. 68 from 16 July 2017). Betulin was extracted from the 
bark by methyl tert-butyric ester (3 times) and then combined 
mixture heated up to 55 °C during 4 h. After solvent removing a 
residue was treated by an aqueous solution of 1% NaOH at boiling 
during 1 h and then washed by water. Finally, betulin was 
recrystallized (ethanol). 5-fluorouracil was purchased from Sigma 
Aldrich (Moscow, Russia), hydrazine sulfate was purchased from 
Sigma Aldrich (Moscow, Russia). Purified water (resistivity ≥18 
MΩ·cm, Millipore, Merck, Darmstadt, Germany), water for injections, 
ethanol 96%, Tween 80, ascorbyl palmitate (Sigma Aldrich, Moscow, 
Russia), peach oil were used. 
Betulin-3,28-diacetate (BDA) and betulonic acid (BA) were 
synthesized according to the methods described in [14,15], 
respectively. Spectral data were the following: FTIR of BDA (ν, sm-1): 
2943 (CH3, CH2, CH), 1728 (C=O), 1033 (C-O); 13C-NMR, ppm: 79.95 
(C-3), 61.56 (C-28), 170.66 (СОАс), 171.6 (СОАс); 99.9% (HPLC). 
FTIR of BA (ν, sm-1): 3413 (O-H), 1705 (C=O), 1643 (C=C), 883 
(=CH2); 13C-NMR, ppm: 216.5 (C-3), 177.3 (C-28), 150.3 (C-20), 109.5 
(C-29); 99.8% (HPLC). 
Biological activity 
Male mice (20–30 g) and male Wistar rats (200–250 g) were 
purchased from the Animal Breeding Facilities “Stolbovaya” 
(Chekhov, Moscow region, Russia). The animals were studied 
according to the criteria outlined by European Convention ET/S 129, 
1986 and directives 86/609 ESC. The animals were handled 
humanely, kept in plastic suspended cages, and placed in a well-
ventilated and clean rat house under suitable conditions at room 
temperature (27±2 °C) and humidity. They were given food and 
water ad libitum and subjected to a natural photoperiod of 12 h light 
and 12 h dark cycle. The animals were allowed two weeks of 
acclimatization before starting all animal model experiments. 
All tumor implantations, blood collections, and sacrifices were 
performed under anesthesia, all efforts being made to minimize 
suffering. 
The Local Ethics Committee of Privolzhsky Research Medical 
University (Russian Federation) approved the study, Protocol No. 16 
from 11 April 2018. 
Biological activity in vitro 
Biological activity in vitro was studied using rat blood stabilized with 
sodium citrate. Erythrocytes were washed twice with 0.9% NaCl by 
centrifugation for 10 min at 1600 g. Suspensions of 0.01% betulin or 
betulin derivative (betulin-3,28-diacetate, betulonic acid) and their 
mixtures with cytostatics were added to the whole blood (1 ml) at 
the doses of 2, 5, and 10 µg per ml. The ROS generation was 
evaluated by chemiluminescent intensity due to the Fenton reaction. 
The lipid peroxidation intensity (LPO) was estimated by the MDA 
level in plasma and erythrocytes by Uchiyama and Mihara methods 
[16]. Superoxide dismutase activity (EC1.15.1.1) was measured in 
erythrocytes using inhibition of adrenaline auto-oxidation [17]. The 
catalytic activity of lactate dehydrogenase (LDH, EC 1.1.1.27) was 
studied in the direct (LDHdirect, substrate–50 mmol sodium lactate) 
and reverse (LDHreverse, substrate–23 mmol sodium pyruvate) 
reactions [18]. The specific activity of the enzymes was calculated 
from the protein concentration analyzed by the modified Lowry 
method [19]. 
Biological activity in vivo 
Transplanted Ehrlich ascites carcinoma (EAC) was studied on mice 
in the experiment. 1 ml of EAC cells containing 1×107 cells was 
transplanted into the abdominal cavity of a mouse. On day six after 
transplantation, the resulting ascites liquid was collected. The cells 
were precipitated at 400 g, thrice washed by 0.15 M NaCl solution, 
and transplanted into the abdominal cavity of another mouse. 
Tumor cells were transplanted 2–3 times for cell culture recovery 
and standardization. The control tumor carrier mouse was prepared 
after the last transplantation and on day six after transplantation, its 
cells were used in the experiment. The tumor cells were thrice 
washed in saline and transplanted into the abdominal cavity of the 
experimental mice (0.8 ml, 1×107 cells·ml−1). 
 
Table 1: The characteristic of animal experimental groups 
Control group  Intact mice 
Control EAC group  EAC-bearing mice 
EAC-5-FU group  EAC-bearing mice treated with 5-fluorouracil (5-FU) 
EAC-HS group  EAC-bearing mice treated with hydrazine sulfate (HS)  
EAC-(BA+5-FU) group  EAC-bearing mice treated with the combination drug of BA with 5-fluorouracil (5-FU) 
EAC-(BA+HS) group  EAC-bearing mice treated with the combination drug of BA with hydrazine sulfate (HS) 
EAC-(BDA+5-FU) group  EAC-bearing mice treated with the combination drug of BDA with 5-fluorouracil (5-FU) 
EAC-(BDA+HS) group  EAC-bearing mice treated with the combination drug of BDA with hydrazine sulfate (HS) 
Abbreviations: EAC–Ehrlich ascites carcinoma, BA–belulonic acid, BDA–betulin-3,28-diacetate. Note: The treatment of animals was carried out once 
a day intraperitoneally (i. p.). 
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Experimental protocol 
Male albino mice were divided into 8 groups, 10 animals (n = 10) in 
each group (table 1). 
On day 11, all the mice were sacrificed by decapitation under 
anesthesia (Zoletil 60 µg·kg−1 “Virbac Sante Animale”, Vauvert, 
France; Xyla 6 mg·kg−1, Interchemie, Venray, The Netherlands). On 
day 11 the ascitic fluid in the peritoneal cavity was carefully 
collected into plastic tubes by injecting the abdominal cavity, and 
then from the opened abdominal cavity with scissors under 
anesthesia and then kept in an ice-cold bath. The volume of the fluid 
was measured using a graduated centrifuge tube. The cytological 
analysis of the ascitic fluid cells was made according to 
Pappenheim`s method with azure-eosin staining and fixation with a 
10% formalin solution [20]. 0.2 ml of the drug, which contains 1.0 
mg of BA or 1.2 mg of BDA, was used. The dose of 5-FU and HS was 
0.32 mg per mouse. Compositions of the used dosage forms are 
shown in table 2. In contrast to BA combined dosage form, the 
cytostatic aqueous solution and BDA oil solution were administrated 
separately in case of BDA dosage form. 
 
Table 2: Drugs compositions 
Group Cytostatic Triterpenoid** Excipients 
EAC-5-FU 5-FU*–48 mg - Water for injections–20.4 ml 
EAC-HS HS*–48 mg - Water for injections–30 ml 
EAC-(BA+5-FU) 5-FU*–64 mg 200 mg Ethanol 96%–4 ml 
Tween 80–4 g 
Water for injections–32 ml 
EAC-(BA+HS) HS*–64 mg 200 mg 
 
Ethanol 96%–4 ml 
Tween 80–4 g 
Water for injections–32 ml 
BDA – 1000 mg Ascorbyl palmitate–20 ml, peach oil–200 ml 
*The amount of cytostatic agent contained in 0.2 ml of the composition solution for i. p. administration corresponded to the dose of 15 mg/kg per 
day for 5-fluorouracil and 16 mg/kg per day for hydrazine sulfate, **The amount of triterpenoid contained in 0.2 ml of the composition solution for 
i. p. administration corresponded to the dose of 50 mg/kg per day. 
 
 
Fig. 2: Chemiluminescent intensity level under the action of triterpenoids and combination drugs with cytostatics at the doses of 2, 5 and 
10 μg per ml in plasma (a, b) and in erythrocytes (c, d) as % of control (ρ<0.05). Values are means±standard deviation (n = 3) 
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Statistical analysis 
Biological activity in vitro was carried out in triplicates. Biological 
activity in vivo was carried out ten times in each group. The results 
expressed as mean±standard deviation. Data were analyzed using 
Microsoft Excel. 
RESULTS 
Antioxidant properties of betulin derivatives and their combinations 
with cytostatic in plasma and erythrocytes in vitro experiment on 
rats. 
Antioxidant and metabolic activities of triterpenoids–betulin (B), 
betulonic acid (BA), betulin-3,28-diacetate (BDA), and their 
combinations with cytostatics (B+5-FU, B+HS, BA+5-FU, BA+HS, 
BDA+5-FU, BDA+HS) at the doses of 10, 5 and 2 μg per ml by 
nontumor rat blood were studied in comparison with the control rat 
blood without treatment taken as 100%. 
The level of chemiluminescent intensity after Fenton reaction both 
in plasma and erythrocytes was the dose-dependent as well 
triterpenoids as the combination of triterpenoids with cytostatics 
(fig. 2 a, b). 
The ROS generation at the doses of 10 and 5 μg per ml only 
increased but did not change at the low doses (2 μg per ml) under 
the action of both: triterpenoids as well as triterpenoids 
combinations with cytostatics. 
The malondialdehyde (MDA) level as a biochemical index of 
lipoperoxidation under the action of B, BA and BDA increased at the 
dose of 5 and 10 μg per ml in plasma only. In contrast, the index did 
not significantly change in erythrocytes (fig. 3 a, b). 
 
 
Fig. 3: MDA level in plasma (a, b) and in erythrocytes (c, d) under the action of triterpenoids and combination drugs at the doses of 2, 5 
and 10 μg per ml as % of control (ρ<0.05); malonic dialdehyde (MDA)plasma–0.81433 μmol·l-1; (MDA)erythrocyte–5.97700 μmol·l-1. Values are 
means±standard deviation (n = 3) 
 
In contrast to these data, the MDA level decreased in response to 
triterpenoids and their combinations with cytostatics at the dose of 
2 μg, except for BDA in plasma. 
An antioxidant effect in relation to lipoperoxidation was most 
pronounced when HS was used as a dosage form component, a 
reduced MDA level in erythrocytes being 78-95% at the low doses. 
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The MDA level in erythrocytes decreased by 39-68% under the 
action of 5-fluorouracil containing low-dosage forms. 
The superoxide dismutase (SOD) activity in response to the action of 
betulin (B), betulonic acid (BA) and betulin-3,28-diacetate (BDA) 
was dose-dependent, but the SOD activity increased under the action 
of each triterpenoid at all doses. The effect of hydrazine sulfate (HS) 
on the SOD activity of combination drugs (B+HS, BA+HS and 
BDA+HS) was the same as that of single triterpenoids, and the SOD 
activity increased by 70-86% at the dose of 2 μg per ml. The result 




Fig. 4: The SOD activity of triterpenes (a) and combination drugs (b) at the doses 2, 5 and 10 μg per ml as % of control (ρ<0.05); SOD–
996.95 RU/mg protein. Values are means±standard deviation (n = 3) 
 
A stable and significant increase in the SOD activity under the 
influence of the combination drugs of 5-fluorouracil was manifested 
at the large (10 μg) and small (2 μg) doses (fig. 4). 
In general, the SOD activity increase under the action of the studied 
drugs shows that the components of the dosage forms containing 
triterpenoids can improve enzyme antioxidant protection.  
Energy metabolism in a cell was evaluated by the lactate 
dehydrogenase (LDH) activity, which is an enzyme in anaerobic 
glycolysis in tumor cells, in which LDH activity is increased 
compared to nontumor cells. 
The effect of triterpenoids on the activity of LDHdirect and LDHreverse was 
dose-dependent, the highest activity in a direct reaction being 
observed at the large dose (10 μg), while at the doses of 5 and 2 μg the 
LDHdirect activity was close to the control. The dependence of LDHreverse 
activity on the structure and the dose of triterpenoids was more 
complicated. At the dose of 2 μg, the LDHreverse activity increased in 
response to betulin, betulin-3,28-diacetate and betulonic acid by 51%, 
31% and 59%, respectively, compared to the control. At the dose of 10 
μg the LDHreverse activity increased under the action of betulin and 
betulin-3,28-diacetate by 64% and 112%, respectively, while under 
the effect of BA the LDHreverse activity was close to the control. 
The increase in the LDHreverse activity under the action of 
triterpenoids promotes the increase of the lactic acid formed mainly 
by M-subunits of LDH (LDHreverse) indicating the improvement in 
energy metabolism in erythrocytes due to anaerobic oxidation, is 
favorable not only for healthy cells but also for tumor cells. 
The increase in the LDH activity under the action of 5-fluorouracil 
was observed in both: direct and reverse reactions, except the 
LDHreverse activity at a dose of 5μg (table 3). The most significant 
increase in LDHdirect activity was found for the combination of 5-
fluorouracil with BDA at the dose of 10 μg (by 75%). The LDHreverse 
activity in response to 5-fluorouracil increased by 100% at the dose 
of 2 μg, and its combination with BDA increased the level of 
LDHreverse by 130% at the dose of 2 μg, and by 33% at the dose of 5 
μg, while at the dose of 10 μg LDHreverse decreased by 20% compared 
with control. 
The LDH activity increased in direct reaction at all doses both of 
betulin, betulonic acid and betulin-3,28-diacetate and that of their 
combinations with cytostatics (hydrazine sulfate and 5-fluorouracil) 
(table 3). In contrast, the LDH activity in a reverse reaction was 
dose-dependent under the action of cytostatics, triterpenoids and 
their combinations. 
The LDHreverse activity increased by 97% at the dose of 2 μg and by 
34% at the dose of 10 μg when treated by pure HS compared to the 
control (table 3). The LDHdirect activity by the combination of HS with 
triterpenoids treatment was similar to that of the control group. 
Under the action of BA+HS combination drug, the LDHreverse activity 
was higher than that of the control group: by 130% at the dose of 2 
μg, and the BDA+HS combination increased the LDHreverse activity by 
161% and by 40% at doses of 2 and 10 μg, respectively (table 3). 
In general, it should be noted that the combination drugs of 
triterpenoids (B, BA and BDA) with cytostatics activated the LDH 
activity in both direct and reverse reactions with an insignificant 
predominance of a reverse reaction. The data differ from our early 
published data about the combination of betulin-3,28-diphosphate 
with hydrazine sulfate and 5-fluorouracil, according to which 
LDHreverse activity was the most pronounced. 
The characteristics of the triterpenoid dosage form in Ehrlich 
carcinoma treatment in mice 
The development of combined dosage forms of betulonic acid and 
cytostatics (5-fluorouracil and hydrazine sulfate) was based on the 
findings of in vitro experiments. The formulations of the dosage 
forms were made, taking into account the ED50 value of the 
cytostatics and the known dose of betulinic acid [9] in mice, which 
was 1 mg per mouse. Combination therapy with betulin-3,28-
diacetate was performed by oil BDA injections at the dose of 1.2 mg 
per mouse, which corresponded to the same molar concentration of 
betulinic acid, and by separate administration of cytostatics. 
The administration of a daily repeated dose of 0.2 ml per mouse (1.0 
mg of BA or 1.2 mg of BDA and 0.32 mg of cytostatics per mouse) for 
11 d showed no abnormal behavioral responses. Mice treated only 
with cytostatics displayed significantly deteriorated health status 
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(wool state, body weight, and behavior) than those in the control 
group or EAC-(BDP+5-FU) and EAC-(BDP+HS) groups. 
After ten days of Ehrlich carcinoma treatment by combination drugs 
of betulonic acid and betulin-3,28-diacetate with 5-FU and HS, more 
than 83±5% of the animals in the experimental groups survived, 
while not more than 70±5% of the animals survived in the control 
groups EAC-5-FU and EAC-HS (table 4). At the same time, the state of 
mice improved by objective indicators (body weight, wool, behavior) 
compared to the control-EAC group. 
 
Table 3: Dose-dependent effects of triterpenoids and its combination with cytostatics on the LDH activity in direct and reverse reactions 
 Dose, µg·ml-1 % of control 
LDHdirect LDHreverse 
B 2 128±8 151±6 
5 106±4 105±8 
10 132±1 164±3 
BA 2 102±5 159±4 
5 115±4 109±5 
10 168±8 91±3 
BDA 2 117±12 131±8 
5 117±3 85±1 
10 207±5 212±7 
5-FU 2 124±2 201±4 
5 102±4 85±12 
10 115±13 163±4 
B+5-FU 2 106±8 131±3 
5 95±1 92±10 
10 101±4 203±5 
BA+5-FU 2 102±3 128±4 
5 112±9 134±1 
10 137±4 62±8 
BDA+5-FU 2 104±5 229±4 
5 120±3 133±3 
10 175±4 80±8 
HS 2 124±2 197±15 
5 136±1 97±3 
10 164±6 134±5 
B+HS 2 109±8 206±3 
5 119±1 125±8 
10 121±7 64±4 
BA+HS 2 120±4 230±13 
5 110±5 84±1 
10 140±8 103±3 
BDA+HS 2 111±3 261±8 
5 120±8 104±5 
10 124±1 140±3 
Values are means±standard deviation (n = 3). Biochemical indexes were taken as 100%: LDHdirect–60.87 nmol NADH·min-1·mg-1 protein; LDHreverse–
125.58 nmol NADH·min-1·mg-1 protein. LDH: lactate dehydrogenase. 
 
Table 4: The effects of betulonic acid (BA) and betulin-3,28-diacetate (BDA) in combination drugs on the biological parameters of EAC-
bearing mice on day 11a 
Group Survival Body weight Ascitic fluid (ml) on d 11 Tumour cellsb Neutrophilc 
d 1 d 11 
Control EAC 3/10 23.1±0.6 29.2±0.5 6.0±0.3 ++ +++ 
EAC-5-FU 8/10 21.8±0.7 26.3±1.1 4.0±0.5 + ++ 
EAC-HS  6/10 22.3±0.6 27.1±0.9 4.5±0.4 + ++ 
EAC-(BA+5-FU) 10/10 23.1±0.5 25.2±0.7 2.3±0.2 - + 
EAC-(BA+HS) 7/10 21.9±0.8 24.3±0.5 2.5±0.1 + ++ 
EAC-(BDA+5-FU) 7/10 22.4±0.5 25.4±0.8 2.1±0.3 + ++ 
EAC-(BDA+HS) 9/10 23.2±0.6 26.3±0.7 2.3±0.4 - + 
Control 10/10 24.5±0.4 25.1±0.3 0 - + 
aValues are means±standard deviation (n = 10). EAC: Ehrlich ascites carcinoma. b-negligible; +tumor cells content is more than 5%;++tumor cells 
content is more than 10%. c+neutrophil content corresponding to that of a healthy animal; ++neutrophil content is twice more than that of a healthy 
animal; +++neutrophil content is thrice more than that of a healthy animal. 
 
On day 11, the ascitic fluid was examined. The fluid volume in the 
control group was negligible, but that in the EAC-control group was 
very large. The amounts of the ascitic fluid in EAC-5-FU and EAC-HS 
groups were one and a half less than that of the EAC-control group. 
In contrast, the ascitic fluid volumes of combination drugs groups 
were thrice less than the volumes of EAC-control group on day 11. 
Histological analysis showed that there were no significant changes 
in the heart tissues in EAC-(BA+5-FU) and EAC-(BA+HS) groups in 
contrast to the control-EAC group and BDA containing groups. The 
oleophilic dosage form with peach oil can explain the cardiotoxicity 
in BDA containing groups. 
The content of neutrophils and tumor cells when treated by BA+5-
FU and BDA+HS combination drugs significantly decreased (table 4). 
The cytological study of ascitic fluid after the treatment by the 
combination drugs BDA+HS and BA+5-FU showed no tumor cells, 
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whereas tumor cells were found in control groups EAC-5-FU and 
EAC-HS. 
DISCUSSION 
Thus, it may be proposed that the capability of all studied 
triterpenoids and their compositions with cytostatics to activate the 
LDH activity in both direct and reverse reactions will lead to the 
apoptosis of tumor cells due to energy metabolism regulation. 
Oxidative processes can also cause an increase in tumor cell 
apoptosis under the action of combination drugs at the doses of 5 
and 10 μg. The first process was due to the ROS excess in plasma 
shown by high chemiluminescence intensity and a high MDA level. 
The second process was manifested as an antioxidant effect in 
erythrocytes indicated by decreased chemiluminescence intensity 
and a decreased MDA level, as well as increased SOD activity. 
Improvement of antioxidant biochemical indexes of blood during 
combined treatment by cytostatics with betulin derivatives is mainly 
due to the effect of triterpenoids. The similar ability of natural 
triterpenoids to exhibit antioxidant properties, reducing the level of 
lipid peroxidation in red blood cells and increasing the activity of 
superoxide dismutase in animals with grafted Ehrlich ascites 
carcinoma, has also been shown in other studies [21-24].  
The inhibition of SOD and CAT activities as a result of tumor growth 
were also reported. Similar findings were observed in EAC bearing 
mice. It has been shown that a decrease in SOD activity in EAC 
bearing mice may be due to loss of Mn2+containing SOD activity in 
EAC cells and the loss of mitochondria, leading to a decrease in total 
SOD activity in the liver [24, 25]. 
It was shown that the 5-FU treatment additionally decreased the 
SOD activity and resulted in about 30% inhibition of SOD activity in 
control and carcinoma-bearing mice [26]. The authors explained 
that these data could be due to the depression of Cu-Zn SOD activity 
by oxidative stress provoked by a high dose of H2O2, similar to the 
inhibition of SOD activity by CoCl2. The authors explained this 
assumption with the proof that Co (II) binds stoichiometrically at the 
zinc site in the SOD protein and the Cu-Co SOD derivative has low 
enzymatic activity.  
The decreased SOD activity was observed in various cancer conditions 
and diminished scavenging of free radicals formed in liver cancer 
conditions [27]. Our data also support a valuable property of betulin 
derivatives in the correction of the SOD activity in cancerous condition, 
in particular in Ehrlich ascites carcinoma treatment. The role of betulin 
derivatives as natural antioxidants obtained from birch bark extracts 
is not only the significant increase of the SOD levels and the MDA level 
decrease of EAC-bearing mice but also the decrease of cytostatics side 
effects. Moreover, the antitumor activity of betulin derivatives may be 
either through the induction of apoptosis or by inhibition of 
neovascularization [4,5]. The free radical hypothesis supported the 
fact that the antioxidants effectively inhibit the tumor, and the 
observed properties may be attributed to the antioxidant and 
antitumor principles present in the betulin contained dosage forms. 
Because the cells of different cancer types exhibit heterogeneity in the 
levels of oxidative stress, associated with various expression levels of 
SOD, the administration of combination forms of cytostatics with 
betulin derivatives at three different doses significantly increased the 
SOD level in a dose-dependent manner. The similar dose-dependent 
antioxidant effect was reported at the administration of methanol 
extract of Dregea volubilis leaves against EAC [22]. 
Some researchers consider the SOD level as a more critical protective 
factor against superoxide radicals, also generated as a by-product of 
oxidative phosphorylation [23]. Although there is no complete evidence 
of the mechanism of hydrazine sulfate action as a cytostatic agent, it is 
believed that its antitumor effect is mainly due to the accumulation of 
metabolic intermediates behind the phosphoenolpyruvate 
carboxykinase block [28]. It can be assumed that the effect of betulin and 
its derivatives in the treatment of hydrazine sulfate is likely to regulate 
the balance between glycolysis and oxidative phosphorylation. 
CONCLUSION 
The study has demonstrated the effectiveness of the combination of 
triterpenoids–betulin, betulonic acid, betulin diacetate, and 
antitumor components (hydrazine sulfate and 5-fluorouracil) in the 
treatment of Ehrlich ascites carcinoma in mice. The animals` state 
and behaviour improved, their survival increased, the volume of 
ascitic fluid decreased by 40-50% during the treatment. There has 
been shown the dose-dependent effect of the drugs on biochemical 
blood indexes, which can be regarded as a prognostic factor in 
reducing the toxic cytostatic dose in the drug. These facts might lead 
to a new strategy for advanced inoperable carcinoma. Improved 
quality of animals` life and a reduced dose of toxic cytostatics are the 
indicators to use combination drugs in palliative medicine. 
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